Journal pre-proof

HIGHLIGHTS

  • who: Petri Reinikainen and collaborators from the Faculty of Medicine and Health Technology and Tampere University and TAUH Cancer Center, Tampere University Hospital, Tampere, Finland have published the research: Journal Pre-proof, in the Journal: (JOURNAL)
  • what: Discussion This study demonstrated that patients treated with RT for early PC had similar HRQoL compared the age-standardized general male population at three years after treatment. __NEWPAGE__Keyword Prostate Cancer; Radiotherapy; Hypofractionated radiotherapy; Quality of Life; 15D instrument; the FACT-P questionnaire The aim of this trial was to investigate, how radiation therapy for the prostate affects HRQoL . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?